R Squared’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9K Buy
1,664
+724
+77% +$6.19K 0.01% 498
2026
Q1
$5.16K Sell
940
-225
-19% -$2.49K ﹤0.01% 477
2025
Q4
$30.8K Buy
1,165
+280
+32% +$5.41K 0.01% 481
2025
Q3
$16.9K Sell
885
-357
-29% -$5.56K 0.01% 532
2025
Q2
$24.1K Buy
+1,242
New +$24.1K 0.01% 435

Other funds holding GUTS

R Squared's GUTS Position: Q2 2026 in Review

R Squared increased its Fractyl Health (GUTS) stake by 77% in Q2 2026, buying an estimated $6.19K and bringing the position to 1,664 shares worth $15.9K. The position accounts for 0.01% of the portfolio, ranked #498.

R Squared first reported a position in GUTS in Q2 2025 and has held it in 5 quarters since. The position peaked at $30.8K in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • R Squared held 1,664 shares of Fractyl Health worth $15.9K as of Q2 2026.
  • R Squared bought 724 Fractyl Health shares in Q2 2026, an estimated $6.19K.
  • Fractyl Health made up 0.01% of R Squared's portfolio in Q2 2026, its #498 holding.
  • R Squared first reported a position in Fractyl Health in Q2 2025 and has held it in 5 quarters since.
  • R Squared's Fractyl Health position peaked at $30.8K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.